CU-20401
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CU-20401, covering 2024-12-10 to 2025-01-22. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Clinical Study of CU-20401 [Phase 2]